Essure May Get Black Box For Risks; FDA Orders Bayer To Do Post-Marketing Study
SILVER SPRING, Md. — The Food and Drug Administration on Feb. 29 ordered Bayer HealthCare Corp. to conduct a clinical study on the safety of the Essure birth control device and...To view the full article, register now.
Already a subscriber? Click here to view full article